Goldman Sachs Maintains Neutral on Definitive Healthcare, Lowers Price Target to $10.5
Portfolio Pulse from Benzinga Newsdesk
Goldman Sachs analyst Kash Rangan has maintained a Neutral rating on Definitive Healthcare (NASDAQ:DH) and lowered the price target from $17 to $10.5.
August 16, 2023 | 12:42 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Goldman Sachs has maintained a Neutral rating on Definitive Healthcare and lowered the price target from $17 to $10.5.
The lowering of the price target by Goldman Sachs indicates a potential decrease in the stock's value. This could lead to a negative short-term impact on Definitive Healthcare's stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100